Deepak Bhatt, Cleveland Clinic, Ohio American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta The idea of adding clopidogrel anti-platelet therapy to standard aspirin therap
Deepak Bhatt, Cleveland Clinic, OhioAmerican College of Cardiology Annual Scientific Session March 11-14, 2006, AtlantaThe idea of adding clopidogrel anti-platelet therapy to standard aspirin therapy among patients with multiple risk factors for coronary disease is not supported by the CHARISMA study findings reported at the ACC conference in Atlanta. But Audio Medica heard from Deepak Bhatt of the Cleveland Clinic that the study found patients with established cardiovascular disease can benefit.
Related Episodes
Remove Thrombus Before Primary Angioplasty!
Felix Zijlstra Felix Zijlstra, University Medical Center Groningen, The Netherlands Thrombus aspiration before percutaneous coronary intervention for acute myocardial infarction has multiple benefits,
Torcetrapib in Patients at High Risk for Coronary Events: ILLUMINATE Trial Latest Results
Philip Barter Gordon Tomaselli REFERENCE: Late Breaking Clinical Trials, Session 2, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida N Engl J Med 2007;357 PHILIP BA